These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6418891)

  • 1. Importance of unbound phenytoin serum levels in head trauma patients.
    Bauer LA; Edwards WA; Dellinger EP; Raisys VA; Brennan C
    J Trauma; 1983 Dec; 23(12):1058-60. PubMed ID: 6418891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised Winter-Tozer equation for normalized phenytoin concentrations in trauma and elderly patients with hypoalbuminemia.
    Anderson GD; Pak C; Doane KW; Griffy KG; Temkin NR; Wilensky AJ; Winn HR
    Ann Pharmacother; 1997 Mar; 31(3):279-84. PubMed ID: 9066931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acute phase response on phenytoin metabolism in neurotrauma patients.
    McKindley DS; Boucher BA; Hess MM; Rodman JH; Feler C; Fabian TC
    J Clin Pharmacol; 1997 Feb; 37(2):129-39. PubMed ID: 9055139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin protein binding in pediatric patients with acute traumatic injury.
    Griebel ML; Kearns GL; Fiser DH; Woody RC; Turley CP
    Crit Care Med; 1990 Apr; 18(4):385-91. PubMed ID: 1969339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
    Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
    Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early post-traumatic epilepsy prophylaxis.
    Young B; Rapp RP; Perrier D; Kostenbauder H; Hackman J; Blacker HM
    Surg Neurol; 1975 Sep; 4(3):339-42. PubMed ID: 809855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of unbound phenytoin in the management of epilepsy.
    Kilpatrick CJ; Wanwimolruk S; Wing LM
    Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury.
    Markowsky SJ; Skaar DJ; Christie JM; Eyer SD; Ehresman DJ
    Ann Pharmacother; 1996 May; 30(5):443-8. PubMed ID: 8740320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic phenytoin in severe head injuries.
    Wohns RN; Wyler AR
    J Neurosurg; 1979 Oct; 51(4):507-9. PubMed ID: 113510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of phenytoin protein binding in epileptic patients.
    DeMonaco HJ; Lawless LM
    Arch Neurol; 1983 Aug; 40(8):481-3. PubMed ID: 6347141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of therapeutic phenytoin plasma levels via intramuscular administration.
    Perrier D; Rapp R; Young B; Kostenbauder H; Cady W; Pancorbo S; Hackman J
    Ann Intern Med; 1976 Sep; 85(3):318-21. PubMed ID: 822764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quantitative effect of serum albumin, serum urea, and valproic acid on unbound phenytoin concentrations in children.
    ter Heine R; van Maarseveen EM; van der Westerlaken MM; Braun KP; Koudijs SM; Berg MJ; Malingré MM
    J Child Neurol; 2014 Jun; 29(6):803-10. PubMed ID: 23670246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM; Wolff DL; Graves NM
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbound plasma phenytoin concentrations measured using enzyme immunoassay technique on the cobas MIRA analyser--in vivo effect of valproic acid.
    Sallustio BC; Morris RG
    Ther Drug Monit; 1992 Feb; 14(1):9-13. PubMed ID: 1546396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
    Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
    Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
    Barth N; Alván G; Borgå O; Sjöqvist F
    Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Unbound Phenytoin Concentrations: Effects of Albumin Concentration and Kidney Dysfunction.
    Montgomery MC; Chou JW; McPharlin TO; Baird GS; Anderson GD
    Pharmacotherapy; 2019 Jul; 39(7):756-766. PubMed ID: 31067355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case study of two methods of administering phenytoin enterally and the subsequent serum phenytoin levels in head-injured patients.
    Bader MK
    J Neurosci Nurs; 1993 Feb; 25(1):57-8. PubMed ID: 8445276
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures.
    Temkin NR; Dikmen SS; Wilensky AJ; Keihm J; Chabal S; Winn HR
    N Engl J Med; 1990 Aug; 323(8):497-502. PubMed ID: 2115976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting unbound phenytoin concentrations in the critically ill neurosurgical patient.
    Mlynarek ME; Peterson EL; Zarowitz BJ
    Ann Pharmacother; 1996 Mar; 30(3):219-23. PubMed ID: 8833553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.